Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Albany, NY, Feb. 03, 2016 -- Driven by the increased sales of medicinal drugs globally, the pharmacovigilance industry will find several opportunities for growth in the coming years, finds a latest report that is now available on MarketResearchReports.biz. The report, titled ‘Global Pharmacovigilance Industry 2015 Market Research Report’, whittles the global market into multiple segments and sub-segments to create a rich and comprehensive analysis.
The findings of the report suggest that thanks to a rise in the number of adverse drug reactions reported across the world, the deployment of pharmacovigilance methods will show a parallel rise. The report, prepared by seasoned industry experts, relies extensively on both primary and secondary research in order to analyze the current dynamics of the global pharmacovigilance industry. This report also identifies key trends that will augur well for the growth of the global pharmacovigilance industry, with outsourcing of pharmacovigilance activities being identified as a major trend.
However, given the sensitive nature of pharmacovigilance, breach of confidential data repositories is a risk that companies in the market need to actively alleviate. For this purpose, joint collaborations might be the way ahead. Collaborations between private players such as life sciences companies and pharmaceutical manufacturers as well as public entities such as regulatory authorities could be seen in the coming years within the pharmacovigilance market. The other restraint that the market for pharmacovigilance is likely to face is a dearth of skilled professionals.
View Press Release at: http://www.marketresearchreports.biz/pressrelease/360
The report on the pharmacovigilance industry begins with a general overview of the industry, where clients can acquaint themselves with basics such as definition and classification of pharmacovigilance. This chapter also discusses the applications of various pharmacovigilance methods and the characteristics of pharmacovigilance. Moving further, the report discusses the barriers to entry that currently exist in this market.
In the subsequent chapters, the report delves on the state of the pharmacovigilance industry in the international context and specifically in China. The competitive landscape is analyzed in detail as part of the analysis of this report, for both global and China markets. The most important development trends are discussed in detail so as to provide industry stakeholders a complete picture of the opportunities that lie within these trends.
Since current policies and new developments have a bearing on the growth trajectory of the global pharmacovigilance industry, understanding them becomes a winning imperative. This is precisely what the report offers. Details of the current and projected revenue of the market as a whole and that of individual segments studied within the pharmacovigilance industry are presented. Revenues of important national markets such as the U.S., China, and Japan are projected separately. The revenue expected to be generated by the pharmacovigilance industry in Europe is also projected in the report.
The leading players that are profiled in the global pharmacovigilance industry report are Oracle, ArisGlobal, Sparta Systems, Extedo, UBC, Sarjen, Ennov, and others.
Related Reports:
Global Pharmaceutical Packaging Market 2016-2020: http://www.marketresearchreports.biz/analysis/502500
US Nuclear Medicine/Radiopharmaceuticals Industry 2015 Market Research Report: http://www.marketresearchreports.biz/analysis/482629
About MarketResearchReports.biz
Marketresearchreports.biz is the most comprehensive collection of market research reports, supporting clients' market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.
MarketResearchReports.biz Mr. Nachiket Ghumare, +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 [email protected] http://www.marketresearchreports.biz/
